109 related articles for article (PubMed ID: 31240409)
21. Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy.
Shen S; Sun CY; Du XJ; Li HJ; Liu Y; Xia JX; Zhu YH; Wang J
Biomaterials; 2015 Nov; 70():71-83. PubMed ID: 26302232
[TBL] [Abstract][Full Text] [Related]
22. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
23. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy.
Guo Y; Zhang Y; Li J; Zhang Y; Lu Y; Jiang X; He X; Ma H; An S; Jiang C
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5444-53. PubMed ID: 25686400
[TBL] [Abstract][Full Text] [Related]
24. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy.
Wang X; Wu F; Li G; Zhang N; Song X; Zheng Y; Gong C; Han B; He G
Acta Biomater; 2018 Jul; 74():414-429. PubMed ID: 29787814
[TBL] [Abstract][Full Text] [Related]
25. Gum arabic-curcumin conjugate micelles with enhanced loading for curcumin delivery to hepatocarcinoma cells.
Sarika PR; James NR; Kumar PR; Raj DK; Kumary TV
Carbohydr Polym; 2015 Dec; 134():167-74. PubMed ID: 26428113
[TBL] [Abstract][Full Text] [Related]
26. Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery.
Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
Mol Pharm; 2018 Feb; 15(2):571-584. PubMed ID: 29313693
[TBL] [Abstract][Full Text] [Related]
27. Additive induced core and corona specific dehydration and ensuing growth and interaction of Pluronic F127 micelles.
Dey J; Kumar S; Nath S; Ganguly R; Aswal VK; Ismail K
J Colloid Interface Sci; 2014 Feb; 415():95-102. PubMed ID: 24267335
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
29. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy.
Zhang J; Zheng Y; Xie X; Wang L; Su Z; Wang Y; Leong KW; Chen M
Mol Pharm; 2017 Nov; 14(11):3644-3659. PubMed ID: 28994600
[TBL] [Abstract][Full Text] [Related]
30. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
31. pH/redox dual-sensitive platinum (IV)-based micelles with greatly enhanced antitumor effect for combination chemotherapy.
He L; Sun M; Cheng X; Xu Y; Lv X; Wang X; Tang R
J Colloid Interface Sci; 2019 Apr; 541():30-41. PubMed ID: 30682591
[TBL] [Abstract][Full Text] [Related]
32. Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma.
Chang L; Wang G; Jia T; Zhang L; Li Y; Han Y; Zhang K; Lin G; Zhang R; Li J; Wang L
Oncotarget; 2016 Apr; 7(17):23988-4004. PubMed ID: 26992211
[TBL] [Abstract][Full Text] [Related]
33. On the hypoxic tumor targeting ability of two chitosan micelles loaded with oil-soluble CdSe quantum dots.
Zhang S; Zhao L; Qiu N; Liu Y; Xu B; Zhu H
Pharm Dev Technol; 2018 Jan; 23(1):87-95. PubMed ID: 28782455
[TBL] [Abstract][Full Text] [Related]
34. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
[TBL] [Abstract][Full Text] [Related]
35. Insights into EPR effect versus lectin-mediated targeted delivery: biodegradable polycarbonate micellar nanoparticles with and without galactose surface decoration.
Ebrahim Attia AB; Oh P; Yang C; Tan JP; Rao N; Hedrick JL; Yang YY; Ge R
Small; 2014 Nov; 10(21):4281-6. PubMed ID: 25091699
[TBL] [Abstract][Full Text] [Related]
36. Peptide-containing aggregates as selective nanocarriers for therapeutics.
Accardo A; Tesauro D; Aloj L; Tarallo L; Arra C; Mangiapia G; Vaccaro M; Pedone C; Paduano L; Morelli G
ChemMedChem; 2008 Apr; 3(4):594-602. PubMed ID: 18167625
[TBL] [Abstract][Full Text] [Related]
37. Cimetidine inhibits epidermal growth factor-induced cell signaling.
Fujikawa T; Shiraha H; Nakanishi Y; Takaoka N; Ueda N; Suzuki M; Shiratori Y
J Gastroenterol Hepatol; 2007 Mar; 22(3):436-43. PubMed ID: 17295779
[TBL] [Abstract][Full Text] [Related]
38. Forward Precision Medicine: Micelles for Active Targeting Driven by Peptides.
Prencipe F; Diaferia C; Rossi F; Ronga L; Tesauro D
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279392
[TBL] [Abstract][Full Text] [Related]
39. Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma.
Abdelmoneem MA; Mahmoud M; Zaky A; Helmy MW; Sallam M; Fang JY; Elkhodairy KA; Elzoghby AO
J Control Release; 2018 Oct; 287():78-93. PubMed ID: 30138716
[TBL] [Abstract][Full Text] [Related]
40. A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma Therapy.
Fang XB; Xu YQ; Chan HF; Wang CM; Zheng Q; Xiao F; Chen MW
Mol Pharm; 2016 Nov; 13(11):3613-3625. PubMed ID: 27768322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
